EUVIMED · CrossrefJournal
Journal of Psoriasis and Psoriatic Arthritis
ISSN 2475-5303 · SAGE Publications
Latest articles
Characteristics of Real-World Patients with Psoriasis Receiving Guselkumab or Interleukin-17 Inhibitors: Data from the Psoriasis Longitudinal Assessment and Registry (PSOLAR)
Lymphocyte-Platelet and Neutrophil-Platelet Aggregates are Associated with Dysregulated Platelet Inflammatory Pathways in Psoriasis
Ixekizumab Treatment Persistence in Psoriatic Arthritis: Response to Joaquin et al
Safety of IL-17A Inhibitors in Patients With Moderate to Severe Psoriasis in a US Claims Data-Based Cohort Study
Sociodemographic Factors Associated With Diagnosed Psoriasis in U.S. Adults: Patterns and Trends From NHANES and NHIS, 2003–2024
Letter From the New Editor-in-Chief
Practical Recommendations on Cardiovascular Risk Evaluation in Patients With Psoriasis and Psoriatic Arthritis for Dermatologists, Rheumatologists, and Primary Care Physicians by the Psoriasis and Psoriatic Arthritis Clinics Multicenter Advancement Network
All-Cause Mortality is Higher in Generalized Pustular Psoriasis (GPP) than Plaque Psoriasis and the General Population: A US-Based Claims Analysis
Lower Drug Survival, Less Satisfaction and More Adverse Events in Females Using Biologics for Psoriasis: Results of the Dutch BioCAPTURE Registry
Ixekizumab Retention Rate and Predictors of Treatment Persistence in Psoriatic Arthritis: Results of an Italian Multicenter Study
Management of Chronic Generalized Pustular Psoriasis: A Review and Expert Opinion
Criteria for Identifying Candidates for Systemic Psoriasis Treatment in the Real World: Application of the International Psoriasis Council Guidelines in Patients in North America
Review of Integrative Medical Therapies for Psoriasis: The Microbiome, Probiotics, Diet, and Mindfulness
Serum Adiponectin Levels as an Independent Marker of Severity of Psoriasis: A Cross-Sectional Analysis
Deucravacitinib: A Novel TYK2 Inhibitor for the Treatment of Moderate-to-Severe Psoriasis
Psoriasis Involving Special Areas is Associated with Worse Quality of Life, Depression, and Limitations in the Ability to Participate in Social Roles and Activities
Retrospective Analysis in Patients With Moderate to Severe Plaque Psoriasis Treated With Tildrakizumab: Real-Life Clinical Data
The Disease Burden of Generalized Pustular Psoriasis: Real-World Evidence From CorEvitas’ Psoriasis Registry
Re-Classification of Psoriasis Severity: Perspectives and Controversy
Machine Learning Applications in the Evaluation and Management of Psoriasis: A Systematic Review
TNF Inhibitor-Induced Psoriasis: Proposed Algorithm for Treatment and Management
What Practitioners Need to Know
Information for Authors
Acitretin for the Treatment of Psoriasis: A Case Report of Long-Lasting Alopecia
A Clinician's Guide to Diagnosing and Managing Psoriatic Arthritis
The Correlation between the Dermatology Life Quality Index and the Psoriasis Area Severity Index
To Biopsy or not to Biopsy: A Review of Guidelines on the use of Methotrexate
2015 National Psoriasis Foundation Research Symposium: Emerging Paradigms and Best Practices in Psoriatic Disease Research and Care
Cutaneous Carcinogenic Risk of Phototherapy: An Updated Comprehensive Review
Assessment of the Use of Adrenocorticotropic Hormone in Psoriatic Arthritis
EUVIMED